Surrogate endpoints in assessment of new drugs in colorectal cancer

Lancet. 2000 Jul 29;356(9227):353-4. doi: 10.1016/S0140-6736(00)02522-8.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Biomarkers, Tumor*
  • Chemotherapy, Adjuvant
  • Colorectal Neoplasms / drug therapy*
  • Colorectal Neoplasms / mortality
  • Colorectal Neoplasms / pathology
  • Humans
  • Neoplasm Metastasis
  • Neoplasm Staging
  • Remission Induction
  • Survival Rate
  • United States
  • United States Food and Drug Administration

Substances

  • Antineoplastic Agents
  • Biomarkers, Tumor